Publicaciones (40) Publicaciones de SERGIO MANUEL GRANADOS PRINCIPAL

2024

  1. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 174

2023

  1. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

    International Journal of Biological Sciences, Vol. 19, Núm. 1, pp. 204-224

2022

  1. Cells electric charge analyses define specific properties for cancer cells activity

    Bioelectrochemistry, Vol. 144

  2. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

    Oncogene, Vol. 41, Núm. 28, pp. 3611-3624

  3. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

    Pharmaceutics, Vol. 14, Núm. 3

2021

  1. Antioxidants for the treatment of breast cancer: Are we there yet?

    Antioxidants, Vol. 10, Núm. 2, pp. 1-44

2020

  1. Drug repurposing for triple-negative breast cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-34

  2. GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels

    Stem Cells Translational Medicine, Vol. 9, Núm. 5, pp. 636-650

2019

  1. Chemical profile and safety assessment of a food-grade acetogenin-enriched antimicrobial extract from avocado seed

    Molecules, Vol. 24, Núm. 13

  2. Heart histopathology and mitochondrial ultrastructure in aged rats fed for 24 months on different unsaturated fats (Virgin olive oil, sunflower oil or fish oil) and affected by different longevity

    Nutrients, Vol. 11, Núm. 10

  3. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3207-3219

  4. Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer

    European Journal of Nutrition, Vol. 58, Núm. 3, pp. 1203-1211

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

  2. Gene pathways associated with mitochondrial function, oxidative stress and telomere length are differentially expressed in the liver of rats fed lifelong on virgin olive, sunflower or fish oils

    Journal of Nutritional Biochemistry, Vol. 52, pp. 36-44

  3. HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway

    Stem Cell Reports, Vol. 10, Núm. 1, pp. 212-227

  4. Pharmacological inhibition of NOS activates ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in triple-negative breast cancer

    Clinical Cancer Research, Vol. 24, Núm. 5, pp. 1152-1162

  5. The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling

    Oncotarget, Vol. 9, Núm. 15, pp. 12201-12211

2017

  1. A plasma metabolomic signature discloses human breast cancer

    Oncotarget, Vol. 8, Núm. 12, pp. 19522-19533

  2. Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

    Targeted Oncology, Vol. 12, Núm. 1, pp. 19-35

2015

  1. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

    Breast Cancer Research, Vol. 17, Núm. 1